Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Researchers, ethicists and unions urge state governance, monitoring and clearer liability for health‑care AI
Summary
Legal scholars, patient-rights advocates, clinicians and union representatives told lawmakers that market incentives alone will not produce safe AI deployments and urged the Assembly to require governance structures, standardized transparency and post‑deployment monitoring as licensure or procurement conditions.
Experts at the Assembly hearing pressed the committee to address a governance gap: many developers disclaim liability in contracts, and most health‑care purchasers have not stood up rigorous pre‑deployment validation or ongoing monitoring for AI tools.
Stanford researcher and lawyer Michelle Mello said market incentives encourage experiments but not the personnel and processes required for robust safety oversight. “The incentives are there for health care organizations to want to try things with AI. But when it comes to the difficult task of…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
